510(k) Report

510(k) · Cleared

Cleared

Anchored Beacon (R) transponder, Anchored transponder, Beacon Care Package - Lung

K170570510(k) TraditionalCleared Apr 6, 2018403-day reviewClass II21 CFR 892.5050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Varian Medical Systems, Inc. · IYE Accelerator, Linear, Medical

Cleared on Apr 6, 2018 as substantially equivalent to K140823 (Varian Medical Systems, Inc., 2014) and 1 other predicate after a 403-day review. Its family tree reaches back 10 generations to 1987. 4 of the 43 devices in its family, counting itself, have a Class I recall.

Decided
Apr 6, 2018
Review
403 days
Class
Class II
Product code
IYE
Recalls
None
Predicates
2

Its longest line of descent runs back 10 generations to K874787 (1987). 42 ancestors in all. No later device cites it as a predicate yet. 4 of the 43 devices in this family, counting this one, have a Class I recall.

Other ancestors, by year cleared 2012: 1 other ancestor2010: 2 other ancestors2007: 3 other ancestors2006: 1 other ancestor2008: 1 other ancestor2004: 2 other ancestors2002: 3 other ancestors2001: 2 other ancestors2000: 4 other ancestors, 1 with a Class I recall11999: 4 other ancestors1998: 2 other ancestors, 2 with a Class I recall21996: 2 other ancestors, 1 with a Class I recall11994: 3 other ancestors1997: 2 other ancestorsK874787 · Modified Palladium Seed Model 100 · Theragenics Corp. · 1987K001070 · Radiomed Source · Radiomed Corp. · 2000K013660 · Genetra · Radiomed Corporation · 2001×2: 2 generations cleared close together, K022326 (2003), K031206 (2003) K080726 · Calypso 4D Localization System · Calypso Medical Technologies, Inc. · 2008K102373 · Calypso System with Dynamic Edge Gating · Calypso Medical Technologies, Inc. · 2010K112768 · Calypso Systems with Dynamic Edge Gating · Calypso Medical Technologies, Inc. · 2011K123137 · Calypso System · Varian Medical Systems · 2012K140823 · Permanent Beacon Transponder/Soft Tissue Beacon Transponder · Varian Medical Systems, Inc. · 201419851990199520002005201020152020
  1. Root · 10 generations backK874787 Modified Palladium Seed Model 100Theragenics Corp. · 1987
  2. 6 generations between
  3. 3 generations backK112768 Calypso Systems with Dynamic Edge GatingCalypso Medical Technologies, Inc. · 2011
  4. 2 generations backK123137 Calypso SystemVarian Medical Systems · 2012
  5. 1 generation backK140823 Permanent Beacon Transponder/Soft Tissue Beacon TransponderVarian Medical Systems, Inc. · 2014
  6. This deviceK170570 Anchored Beacon (R) transponder, Anchored transponder, Beacon Care…Varian Medical Systems, Inc. · 2018
Show all 10 generations
  1. Root · 10 generations backK874787 Modified Palladium Seed Model 100Theragenics Corp. · 1987
  2. 9 generations backK001070 Radiomed SourceRadiomed Corp. · 2000
  3. 8 generations backK013660 GenetraRadiomed Corporation · 2001
  4. 7 generations backK022326 Radiomed MarkerRadiomed Corporation · 2003
  5. 6 generations backK031206 Radiomed Soft Tissue MarkerRadiomed Corp. · 2003
  6. 5 generations backK080726 Calypso 4D Localization SystemCalypso Medical Technologies, Inc. · 2008
  7. 4 generations backK102373 Calypso System with Dynamic Edge GatingCalypso Medical Technologies, Inc. · 2010
  8. 3 generations backK112768 Calypso Systems with Dynamic Edge GatingCalypso Medical Technologies, Inc. · 2011
  9. 2 generations backK123137 Calypso SystemVarian Medical Systems · 2012
  10. 1 generation backK140823 Permanent Beacon Transponder/Soft Tissue Beacon TransponderVarian Medical Systems, Inc. · 2014
  11. This deviceK170570 Anchored Beacon (R) transponder, Anchored transponder, Beacon Care…Varian Medical Systems, Inc. · 2018

Class I recalls in this family

View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−10K874787Modified Palladium Seed Model 100Theragenics Corp.1987—
−9K001070Radiomed SourceRadiomed Corp.2000—
−8K013660GenetraRadiomed Corporation2001—
−7K022326Radiomed MarkerRadiomed Corporation2003—
−6K031206Radiomed Soft Tissue MarkerRadiomed Corp.2003—
−5K080726Calypso 4D Localization SystemCalypso Medical Technologies, Inc.2008—
−4K102373Calypso System with Dynamic Edge GatingCalypso Medical Technologies, Inc.2010—
−3K112768Calypso Systems with Dynamic Edge GatingCalypso Medical Technologies, Inc.2011—
−2K123137Calypso SystemVarian Medical Systems2012—
−1K140823Permanent Beacon Transponder/Soft Tissue Beacon TransponderVarian Medical Systems, Inc.2014—
0 (this device)K170570Anchored Beacon (R) transponder, Anchored transponder, Beacon Care Package -…Varian Medical Systems, Inc.2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199430
199621
199720
199822
199940
200041
200120
200230
200420
200610
200730
200810
201020
201210
FIG. 1 — Lineage of K170570, 1987–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

4 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new IYE device

  1. #1 K252977 Halcyon, Ethos Radiotherapy System (5.0)score 18.8 · 18 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K140823Permanent Beacon Transponder/Soft Tissue Beacon Transponder
Summary page 4
…ed transponder Beacon® Care Package - Lung Fiducial marker Medical charged-particle radiation therapy system CFR 892.5050 Class 11 IYE Permanent Beacon transponder (K140823) The Anchored Beacon® transponder is a small passive implant, intended for permanent implantation in small airways in the lung.…
Varian Medical Systems, Inc.2014—
*K120796Superdimension Nitinol/Gold Fiducial Marker
Summary page 5
…permanently implanted in the lung. The selected predicates are the following fiducial markers: the Soft Tissue Transponder 14G (K140823) and the superlock cobra marker (K120796). A comparison of the similarities and differences of the intended use/indications for use, technology, and other characteristics…
Superdimension, Inc.2012—

Also cleared against K140823: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (4 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K994270Instatrak 3000 System with Fluorotrak Module, Model IT3000Visualization Technology, Inc. · 2000 · 3 generations back · ◆ in the 2000 ancestors bar of FIG. 12 Class I recalls
  • K983529Instatrak 3000Visualization Technology, Inc. · 1998 · 3 generations back · ◆ in the 1998 ancestors bar of FIG. 11 Class I recall
  • K960330InstatrakVisualization Technology, Inc. · 1996 · 3 generations back · ◆ in the 1996 ancestors bar of FIG. 11 Class I recall
  • K981998Pediatric Instatrak SystemVisualization Technology, Inc. · 1998 · 4 generations back · ◆ in the 1998 ancestors bar of FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 31 years and passes through 6 companies; a new generation was cleared every 1.6 years on median.
  • 9 of the 42 ancestors have a recall of any class; 4 have a Class I recall.
  • 1 other device also cites its predicate K140823.

How does its category compare?

All IYE devices

IYE Accelerator, Linear, Medical: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · IYE

12in 2025

2007: 232008: 142009: 202010: 232011: 112012: 282013: 182014: 202015: 202016: 212017: 232018: 212019: 192020: 202021: 192022: 122023: 182024: 92025: 122026 (partial year): 14
2007high 28 (2012) · low 9 (2024)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · IYE

170in 2025

2007: 44 days median2008: 69 days median2009: 63 days median2010: 74 days median2011: 94 days median2012: 106 days median2013: 88 days median2014: 100 days median2015: 108 days median2016: 97 days median2017: 94 days median2018: 58 days median2019: 83 days median2020: 67 days median2021: 86 days median2022: 172 days median2023: 129 days median2024: 239 days median2025: 170 days median2026 (partial year): 120 days median
2007high 239 (2024) · low 44 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · IYE

1in 2025

2007: 782008: 492009: 222010: 272011: 732012: 202013: 112014: 142015: 82016: 72017: 72018: 72019: 22020: 42021: 52022: 32023: 72024: 12025: 12026 (partial year): 4
2007high 78 (2007) · low 1 (2024)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · IYE

101in 2025

2007: 1552008: 1142009: 1742010: 2462011: 2802012: 1282013: 962014: 1242015: 1002016: 972017: 1252018: 852019: 912020: 742021: 682022: 662023: 1282024: 812025: 101
2007high 280 (2011) · low 66 (2022)2025

MAUDE reports naming product code IYE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007234478155
2008146949114
2009206322174
2010237427246
2011119473280
20122810620128
201318881196
20142010014124
2015201088100
20162197797
201723947125
20182158785
20191983291
20202067474
20211986568
202212172366
2023181297128
20249239181
2025121701101
2026141204—

What is it indicated for?

The Calypso System is intended for use as an adjunct in treatment planning and radiation therapy, to align and/or monitor the patient’s position relative to the isocenter of a radiation therapy system. The Calypso System provides accurate, precise, and continuous localization of a treatment isocenter by using two or more Beacon transponders.

Anchored Beacon transponders are indicated for permanent implantation in small airways in the lung to align and/or monitor the internal position of targets that move with respiratory and other patient motion in real time during radiation therapy.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K170570: Anchored Beacon (R) transponder, Anchored transponder, Beacon Care Package - Lung.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K170570

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026